Document is current

Article History

Received: 3 April 2023

Accepted: 29 July 2023

First Online: 9 August 2023

Declarations

:

: According to the Indian Council for Medical Research (ICMR) National Ethical Guidelines [23] , any research on "educational practises such as instructional strategies or the effectiveness of or comparison among instructional techniques, curricula, or classroom management methods" can be exempted from ethics committee review. The ICMR further emphasised that ethics committee approval is mandatory in any biomedical, social, and behavioural health research involving human participants and biological material. According to the above two statements, there is no requirement for ethics committee approval in the context of our manuscript as there was no human/subject involvement (active/passive) or use of human tissue samples and all of the data utilised to generate the consensus guideline were available in the public domain.The consent page for participation of experts was attached as the first page of the electronic sheet shared with all participants. Only after the participant agreed to participate could we proceed to the second page. Participants provided their independent opinion based on their prior experience. To ensure the privacy of participants' personal data, the final responses of all participants were auto generated in the form of final percentages and graphs. All experiments were performed in accordance with relevant guidelines and regulations.

: Because patient participation was not required in this study, no consent was required for publication form patients. However, all experts were aware of the study's objectives, as well as the fact that the study's findings would be published and consented for publication.

: Dr. TP Sahoo received speaker bureau from Roche, AstraZeneca, Eli Lilly, DRL; Honorarium from Roche, AstraZeneca, Eli Lilly, Glenmark, MSD, DRL, Merck. Dr. Sandeep Batra received honorarium from DRL, Intas, Roche, MSD, Pfizer. Dr. Chirag Desai received speaker bureau from Roche, Pfizer, Novartis, MSD, Biocon, DRL. Dr. Rajat Saha received honorarium from Intas. Dr. Arun Philips received speaker bureau from Eli Lilly. Dr. G Biswas received honorarium form DRL, Intas, Zydus, Eli Lilly; Speaker bureau from Eli Lilly, Intas, Zydus. Dr. Boman Dabhar received speaker bureau from Roche, AstraZeneca; Dr. Sagar Bhagat, Dr. Saiprasad Patil, Dr. Hanmant Barkate are employees of Glenmark Pharmaceuticals Ltd. who contributed toward literature search and manuscript writing. The design or procedure of the consensus and the content of the paper are in no way influenced by the grant provider. Glenmark had no influence on the participating experts’ opinions or final consensus. Dr. Shyam Agarwal, Dr. Amit Rautan, Dr. Vijay Agarwal, Dr. P S Dattatreya, Dr. PN Mohapatra, Dr. Chetan Deshmukh declares no competing interests.